On September 29, 2023, the U.S. Food and Drug Administration ("FDA") released a proposed rule that would affirm FDA's position that laboratory developed tests ("LDTs").
Acute Care Syndromic Testing Market Positioned for Explosive Growth, BIS Research Report Forecasts $8 44 Billion Market Value by 2033 texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Acute Care Syndromic Testing Market Positioned for Explosive Growth, BIS Research Report Forecasts $8 44 Billion Market Value by 2033 bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.
Further Broadens Reach of BioCode® MDx-3000 System into Hospitals and Reference Laboratories in the United States
U.S. Distribution of the Automated High Throughput Multiplex Molecular. | May 8, 2023